Tiana Baghdikian is an associate in the Orange County office of Latham & Watkins and a member of the firm’s Corporate Department. She is currently the Global Leader of Latham's First Generation Professionals' Affinity Group.

Ms. Baghdikian represents both public and private companies, particularly in the technology and life sciences industries. She advises clients across a broad range of corporate transactions, including mergers and acquisitions for strategic clients, capital markets transactions, and corporate governance matters. 

In addition to her commercial work, Ms. Baghdikian maintains an active pro bono practice and serves on Latham’s Pro Bono committee.

Ms. Baghdikian received her JD from Columbia Law School where she was named a Harlan Fiske Stone Scholar all three years. While in law school, Ms. Baghdikian was an articles editor for the Science and Technology Law Review and served on both the boards of the California Society and the Society for Law, Science and Technology.

Prior to law school, Ms. Baghdikian received her BS in bioengineering as a Regents Scholar and Alumni Scholar from the University of California - Los Angeles, where she graduated cum laude.

Ms. Baghdikian's representative experience, with an emphasis on mergers & acquisitions work, includes advising on the following transactions:

  • Tapestry, Inc. in its pending US$8.5 billion acquisition of Capri Holdings Limited
  • Icosavax, Inc. in its US$1.1 billion acquisition by AstraZeneca
  • Bolt Threads, Inc. in its business combination with Golden Arrow Merger
  • Switch, Inc. in its US$11 billion acquisition by affiliates of DigitalBridge Group and IFM Investors
  • Cloudways in its US$350 million acquisition by DigitalOcean Holdings
  • Joby Aviation in its US$4.5 billion business combination with Reinvent Technology Partners
  • Ouster, Inc. in its US$400 million merger of equals with Velodyne Lidar, Inc. 
  • Owlet Baby Care Inc. in connection with capital markets matters relating to its US$1.39 billion merger with Sandbridge Acquisition Corporation
  • Ouster, Inc. in its US$1.9 billion business combination with Colonnade Acquisition, and in Ouster’s acquisition of Sense Photonics
  • Amgen, Inc. in its US$900 million acquisition of Teneobio
  • Realty Income Corporation in its acquisition of VEREIT, Inc.
  • Playtika in its US$1.9 billion initial public offering 
  • Numerous follow-on offerings for public companies, especially in the life sciences industries 

Bar Qualification

  • California

Education

  • JD, Columbia Law School, 2020
    Harlan Fiske Stone Scholar
  • BS in Bioengineering, University of California, Los Angeles, 2017
    cum laude